Roos M. Mohede
Papers
1
Total Citations
30
H-Index
1
About
Dr. Roos M. Mohede is a leading clinical researcher in urologic oncology, with a primary focus on improving outcomes for men with prostate cancer through advanced imaging and precision radiotherapy. Her most cited work, a landmark 2022 study, demonstrates that the use of Prostate-Specific Membrane Antigen (PSMA) PET/CT significantly improves oncological outcomes in patients undergoing salvage radiation therapy for biochemical recurrence. This research, which has garnered 30 citations, provides compelling evidence that PSMA PET/CT’s superior diagnostic accuracy—detecting cancer deposits missed by conventional imaging—directly translates into better clinical management and patient survival. Dr. Mohede’s contributions are pivotal in shifting the standard of care toward molecular imaging-guided salvage treatment, offering renewed hope for men facing recurrent disease. Her work stands at the intersection of nuclear medicine and radiation oncology, showcasing how advanced diagnostics can personalize and enhance therapeutic efficacy. A rising authority in the field, Dr. Mohede’s research continues to shape evidence-based protocols for managing biochemically recurrent prostate cancer.
Research Focus
Key Achievements
Top Papers
- 1